Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Magris Talc is North America's leading fully integrated talc producer and mineral mining group with over 100 years of operating history. The company supplies approximately 50% of North America’s talc market and operates mines and processing plants in the United States and Canada. Its products are used globally by manufacturers in industries such as polymers, paints & coatings, pharmaceuticals (as an excipient/mineral ingredient), building products, paper, automotive components, and more[1][2][3][6].
The parent organization—Magris Performance Materials—also owns Niobec (niobium production). The group emphasizes sustainability through vertically integrated operations with a low environmental footprint[1][2].
While talc can be used as an excipient in pharmaceutical manufacturing or for certain healthcare applications as an inert mineral additive[6], the core business of Magris Talc itself does not focus on therapeutics or drug development.
No clinical pipeline exists; the company's main activities are mining/extraction and supply of industrial minerals.
Leadership includes Aaron Regent (Founder/Chairman/CEO), Matthew Fenton (President/CFO), Scott Bergen (VP Commercial & Corporate Affairs), Eric Colby (VP Operations)[1].
Headquarters are located at 333 Bay St Ste 1101, Toronto, Ontario M5H 2R2 Canada[5]. U.S. operations include sites in Three Forks MT and Houston TX[4][7].
Estimated revenue ranges from $5M–$44M USD annually; employee count estimated at ~80 people[5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Magris Talc.